Macderlun Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-07-2024
- Paid Up Capital ₹ 1.00 M
as on 29-07-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 53.94%
(FY 2023)
- Profit 139.17%
(FY 2023)
- Ebitda 350.58%
(FY 2023)
- Net Worth 22.66%
(FY 2023)
- Total Assets -9.77%
(FY 2023)
About Macderlun Specialty Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Wang Kang and Srivardhan Gayam serve as directors at the Company.
- CIN/LLPIN
U24304KA2019PTC124063
- Company No.
124063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Macderlun Specialty Chemicals Private Limited offer?
Macderlun Specialty Chemicals Private Limited offers a wide range of products and services, including Rust & Corrosion Protection Products, Rust Preventives.
Who are the key members and board of directors at Macderlun Specialty Chemicals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Wang Kang | Director | 03-May-2019 | Current |
Srivardhan Gayam | Director | 03-May-2019 | Current |
Financial Performance of Macderlun Specialty Chemicals.
Macderlun Specialty Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.94% increase. The company also saw a substantial improvement in profitability, with a 139.17% increase in profit. The company's net worth Soared by an impressive increase of 22.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Macderlun Specialty Chemicals?
In 2023, Macderlun Specialty Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sanhe Trade And Consultancy Private LimitedActive 5 years 6 months
Srivardhan Gayam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Macderlun Specialty Chemicals?
Unlock and access historical data on people associated with Macderlun Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macderlun Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macderlun Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.